Heike Peulen

2.9k total citations · 2 hit papers
42 papers, 1.8k citations indexed

About

Heike Peulen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Heike Peulen has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Heike Peulen's work include Lung Cancer Diagnosis and Treatment (17 papers), Advanced Radiotherapy Techniques (14 papers) and Colorectal Cancer Surgical Treatments (12 papers). Heike Peulen is often cited by papers focused on Lung Cancer Diagnosis and Treatment (17 papers), Advanced Radiotherapy Techniques (14 papers) and Colorectal Cancer Surgical Treatments (12 papers). Heike Peulen collaborates with scholars based in Netherlands, Germany and Switzerland. Heike Peulen's co-authors include Paul Baas, Willemijn S.M.E. Theelen, Joachim G.J.V. Aerts, Idris Bahce, J. Belderbos, Jan‐Jakob Sonke, Ferry Lalezari, Adrianus J. de Langen, Kim Monkhorst and Vincent van der Noort and has published in prestigious journals such as Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Heike Peulen

41 papers receiving 1.8k citations

Hit Papers

Effect of Pembrolizumab After Stereotactic Body Radiother... 2019 2026 2021 2023 2019 2020 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer
    2019 651 citations Willemijn S.M.E. Theelen, Heike Peulen et al. profile →
  2. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
    2020 353 citations Willemijn S.M.E. Theelen, Dawei Chen et al. The Lancet Respiratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heike Peulen Netherlands 17 1.1k 983 551 499 276 42 1.8k
Quynh-Nhu Nguyen United States 23 1.0k 1.0× 540 0.5× 479 0.9× 332 0.7× 149 0.5× 44 1.7k
Panagiotis Balermpas Germany 23 566 0.5× 713 0.7× 307 0.6× 352 0.7× 256 0.9× 115 1.7k
Merina Ahmed United Kingdom 18 698 0.6× 440 0.4× 457 0.8× 427 0.9× 58 0.2× 44 1.4k
Aaron T. Wild United States 21 654 0.6× 1.3k 1.4× 259 0.5× 273 0.5× 171 0.6× 53 2.0k
Ferry Lalezari Netherlands 15 1.0k 0.9× 1.0k 1.1× 77 0.1× 434 0.9× 312 1.1× 33 1.7k
Fiorenza De Rose Italy 27 946 0.9× 538 0.5× 685 1.2× 450 0.9× 37 0.1× 89 1.7k
Michael D. Chuong United States 23 1.2k 1.1× 1.2k 1.2× 525 1.0× 415 0.8× 42 0.2× 157 2.2k
Khinh Ranh Voong United States 20 711 0.7× 620 0.6× 270 0.5× 210 0.4× 57 0.2× 66 1.3k
Yuzuru Niibe Japan 25 2.6k 2.4× 743 0.8× 1.5k 2.8× 1.0k 2.0× 77 0.3× 77 3.4k
N.M. Woody United States 21 611 0.6× 251 0.3× 381 0.7× 247 0.5× 86 0.3× 124 1.3k

Countries citing papers authored by Heike Peulen

Since Specialization
Citations

This map shows the geographic impact of Heike Peulen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heike Peulen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heike Peulen more than expected).

Fields of papers citing papers by Heike Peulen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heike Peulen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heike Peulen. The network helps show where Heike Peulen may publish in the future.

Co-authorship network of co-authors of Heike Peulen

This figure shows the co-authorship network connecting the top 25 collaborators of Heike Peulen. A scholar is included among the top collaborators of Heike Peulen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heike Peulen. Heike Peulen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greto, Daniela, Mieke Van Hemelrijck, Felix Boakye Oppong, et al.. (2023). 2140P Short-term quality-of-life after metastases-directed SBRT: Results of the prospective ESTRO & EORTC OligoCare cohort. Annals of Oncology. 34. S1115–S1115. 1 indexed citations
2.
Dries, Wim, Jeltsje S. Cnossen, Jacqueline Theuws, et al.. (2022). Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer. Journal of Contemporary Brachytherapy. 14(4). 370–378. 3 indexed citations
3.
Hupkens, B., Marnix G. Witte, Philip Meijnen, et al.. (2022). Development of a consensus-based delineation guideline for locally recurrent rectal cancer. Radiotherapy and Oncology. 177. 214–221. 4 indexed citations
4.
Schaap, Dennis P., Grard A. P. Nieuwenhuijzen, Johanne G. Bloemen, et al.. (2021). Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control study. European Journal of Surgical Oncology. 47(9). 2429–2435. 10 indexed citations
5.
Heuvel, Michel M. van den, Judi van Diessen, Heike Peulen, et al.. (2020). Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer. Clinical Cancer Research. 27(5). 1256–1266. 39 indexed citations
6.
Kusters, Miranda, Grard A. P. Nieuwenhuijzen, Johanne G. Bloemen, et al.. (2020). Improved Outcomes for Responders After Treatment with Induction Chemotherapy and Chemo(re)irradiation for Locally Recurrent Rectal Cancer. Annals of Surgical Oncology. 27(9). 3503–3513. 22 indexed citations
7.
Theelen, Willemijn S.M.E., Dawei Chen, Vivek Verma, et al.. (2020). Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials. The Lancet Respiratory Medicine. 9(5). 467–475. 353 indexed citations breakdown →
8.
Werkhoven, Erik van, Michel M. van den Heuvel, Heike Peulen, et al.. (2019). Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib. BMC Cancer. 19(1). 901–901. 31 indexed citations
9.
Sonke, Jan‐Jakob, Ursula Nestle, Heike Peulen, et al.. (2018). Quality assurance of four-dimensional computed tomography in a multicentre trial of stereotactic body radiotherapy of centrally located lung tumours. Physics and Imaging in Radiation Oncology. 8. 57–62. 14 indexed citations
10.
Peulen, Heike, Matthias Gückenberger, Frederick Mantel, et al.. (2017). Dose to heart substructures is associated with non-cancer death after SBRT in stage I–II NSCLC patients. Radiotherapy and Oncology. 123(3). 370–375. 126 indexed citations
11.
Theelen, Willemijn S.M.E., Ferry Lalezari, Michel M. van den Heuvel, Paul Baas, & Heike Peulen. (2017). PUB013 Randomized Phase II Study of Pembrolizumab after SBRT versus Pembrolizumab Alone in Patients with Advanced NSCLC, Preliminary Results. Journal of Thoracic Oncology. 12(1). S1453–S1453. 4 indexed citations
12.
Giuliani, Meredith, Andrew Hope, Matthias Gückenberger, et al.. (2017). Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 98(4). 893–899. 13 indexed citations
13.
Peulen, Heike, et al.. (2017). Dose–effect analysis of radiation induced rib fractures after thoracic SBRT. Radiotherapy and Oncology. 123(2). 176–181. 28 indexed citations
14.
Giuliani, Meredith, Andrew Hope, V.S. Mangona, et al.. (2016). Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group. Clinical Lung Cancer. 18(2). 162–168. 19 indexed citations
15.
Peulen, Heike, Frederick Mantel, Matthias Gückenberger, et al.. (2016). Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(1). 134–141. 29 indexed citations
16.
Rossi, Maddalena, Heike Peulen, J. Belderbos, & Jan‐Jakob Sonke. (2016). Intrafraction Motion in Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy. International Journal of Radiation Oncology*Biology*Physics. 95(2). 835–843. 18 indexed citations
17.
Peulen, Heike, et al.. (2015). Validation of automatic segmentation of ribs for NTCP modeling. Radiotherapy and Oncology. 118(3). 528–534. 7 indexed citations
18.
Witte, Marnix G., Georgy Shakirin, Antonetta C. Houweling, Heike Peulen, & Marcel van Herk. (2011). Dealing with geometric uncertainties in dose painting by numbers: Introducing the ΔVH1This work was supported by Dutch Cancer Society grant 2007-3895.1. Radiotherapy and Oncology. 100(3). 402–406. 28 indexed citations
19.
Peulen, Heike, Kristin Karlsson, Karin Lindberg, et al.. (2011). Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy. Radiotherapy and Oncology. 101(2). 260–266. 92 indexed citations
20.
Vanfleteren, Lowie E.G.W., Heike Peulen, David Creytens, et al.. (2009). Complete metabolic remission of an irresectable mediastinal solitary fibrous tumour with concurrent chemoradiation. Thorax. 64(9). 822–823. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quynh-Nhu Nguyen Breakdown of academic impact, for papers by Panagiotis Balermpas Breakdown of academic impact, for papers by Merina Ahmed Breakdown of academic impact, for papers by Aaron T. Wild Breakdown of academic impact, for papers by Ferry Lalezari Breakdown of academic impact, for papers by Fiorenza De Rose Breakdown of academic impact, for papers by Michael D. Chuong Breakdown of academic impact, for papers by Khinh Ranh Voong Breakdown of academic impact, for papers by Yuzuru Niibe Breakdown of academic impact, for papers by N.M. Woody
Rankless by CCL
2026